Although TNF-α is not as relevant as interleukin-6 on the cytokine storm presented in severe COVID-19 patients (Karki and Kanneganti, 2021), anti-TNF-α drug repositioning for COVID-19 has been proposed (Stebbing et al., 2020). The gene discussed is TNF; the disease is COVID-19.